# Oral Microbiota and Type 2 Diabetes: Interactions, Potential Mechanisms, and Preventive Strategies

**Authors:** Zifu Ni, Zihan Ni, Yining Wang, Qi Wu, Zhenxi Yang, Yuqi Guo

PMC · DOI: 10.3390/microorganisms14020336 · Microorganisms · 2026-02-02

## TL;DR

This review explores how the oral microbiome interacts with type 2 diabetes, affecting inflammation and metabolism, and suggests ways to manage diabetes through oral health.

## Contribution

The paper provides a comprehensive overview of the bidirectional relationship between oral microbiota and T2DM, emphasizing novel mechanisms and preventive strategies.

## Key findings

- Oral microbiota dysbiosis contributes to systemic inflammation and insulin resistance in T2DM.
- Hyperglycemia and immune impairment in T2DM worsen oral diseases like periodontitis.
- Modulating the oral microbiota offers potential for T2DM prevention and integrative management.

## Abstract

The oral cavity harbors the second-largest and one of the most diverse microbial communities in the human body, playing a critical role in maintaining local and systemic health. Type 2 diabetes mellitus (T2DM), a chronic metabolic disease accounting for nearly 90% of all diabetes cases, has shown rapidly increasing global prevalence. Growing clinical and experimental evidence indicates a strong bidirectional relationship between oral microbiota dysbiosis and T2DM. Imbalanced oral microbial communities can contribute to systemic inflammation, insulin resistance, and metabolic dysregulation, while hyperglycemia and impaired immunity in T2DM promote oral diseases such as periodontitis, xerostomia, and mucosal infections. This review summarizes current research on the interactions between oral microbiota and T2DM, highlighting their clinical correlations, underlying mechanisms, and mutual influences on inflammation, microbial composition, and metabolic pathways. We also discuss emerging strategies for T2DM prevention and management through oral microbiota modulation. These insights may provide new perspectives for early diagnosis, targeted intervention, and integrative management of T2DM.

## Linked entities

- **Diseases:** Type 2 diabetes mellitus (MONDO:0005148), periodontitis (MONDO:0005076)

## Full-text entities

- **Genes:** CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, GLP1R (glucagon like peptide 1 receptor) [NCBI Gene 2740] {aka GLP-1, GLP-1-R, GLP-1R}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, GCG (glucagon) [NCBI Gene 2641] {aka GLP-1, GLP1, GLP2, GRPP}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, TLR2 (toll like receptor 2) [NCBI Gene 7097] {aka CD282, TIL4}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, IL13 (interleukin 13) [NCBI Gene 3596] {aka IL-13, P600}, PYCARD (PYD and CARD domain containing) [NCBI Gene 29108] {aka ASC, CARD5, TMS, TMS-1, TMS1}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}, PYY (peptide YY) [NCBI Gene 5697] {aka PYY-I, PYY1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}
- **Diseases:** metabolic dysregulation (MESH:D021081), metabolic disease (MESH:D008659), systemic diseases (MESH:D034721), autoimmune (MESH:D001327), oral diseases (MESH:D009059), obesity (MESH:D009765), pneumonia (MESH:D011014), oral cancer (MESH:D009062), diabetes (MESH:D003920), Microbial Dysbiosis (MESH:D064806), tumor (MESH:D009369), impaired glucose metabolism (MESH:D044882), prediabetes (MESH:D011236), taste disorders (MESH:D013651), metabolic disturbances (MESH:D024821), Chronic hyperglycemia (MESH:D006943), impaired wound healing (MESH:D014947), liver abscesses (MESH:D008100), Periodontitis (MESH:D010518), gingival inflammation (MESH:D007249), impaired immunity (MESH:D020274), brain abscesses (MESH:D001922), periodontal disease (MESH:D010510), immune dysregulation (OMIM:614878), diabetic nephropathy (MESH:D003928), impaired glucose tolerance (MESH:D018149), aphthous ulcers (MESH:D013281), -autoimmune chronic diseases (MESH:D019693), endocarditis (MESH:D004696), IBD (MESH:D015212), T2DM (MESH:D003924), xerostomia (MESH:D014987), type 1 diabetes (MESH:D003922), bacteremia (MESH:D016470), diabetic retinopathy (MESH:D003930), infection (MESH:D007239), cardiovascular disease (MESH:D002318), IR (MESH:D007333), periodontal bone loss (MESH:D016301), gingivitis (MESH:D005891), endotoxemia (MESH:D019446), diabetic foot (MESH:D017719), dental caries (MESH:D003731), colorectal cancer (MESH:D015179), atherosclerosis (MESH:D050197), hyperglycemic (MESH:D006944)
- **Chemicals:** blood glucose (MESH:D001786), amoxicillin (MESH:D000658), Nitric oxide (MESH:D009569), AGEs (MESH:D017127), iron (MESH:D007501), metronidazole (MESH:D008795), succinate (MESH:D019802), Nitrate (MESH:D009566), sugar (MESH:D000073893), acetate (MESH:D000085), SCFAs (MESH:D005232), glucose (MESH:D005947), Prebiotics (MESH:D056692), LPS (MESH:D008070), nitrite (MESH:D009573), Butyrate (MESH:D002087), carbohydrate (MESH:D002241), propionate (MESH:D011422)
- **Species:** Actinomycetota (actinobacteria, phylum) [taxon 201174], Fungi (kingdom) [taxon 4751], Neisseria (genus) [taxon 482], Veillonella (genus) [taxon 29465], Actinomyces (genus) [taxon 1654], Eikenella corrodens (species) [taxon 539], Prevotella intermedia (species) [taxon 28131], Capnocytophaga (genus) [taxon 1016], Phocaeicola abscessus (species) [taxon 555313], Pseudomonadota (proteobacteria, phylum) [taxon 1224], Mus musculus (house mouse, species) [taxon 10090], Pseudomonas aeruginosa (species) [taxon 287], [Eubacterium] sulci (species) [taxon 143393], Lactobacillus (genus) [taxon 1578], Atopobium (genus) [taxon 1380], Acinetobacter nosocomialis (species) [taxon 106654], Aggregatibacter actinomycetemcomitans (species) [taxon 714], Streptococcus mutans (species) [taxon 1309], Treponema denticola (species) [taxon 158], Streptococcus salivarius (species) [taxon 1304], Hoylesella oralis (species) [taxon 28134], Solobacterium moorei (species) [taxon 102148], gut metagenome (species) [taxon 749906], Bacillota (clostridial firmicutes, phylum) [taxon 1239], Megasphaera micronuciformis (species) [taxon 187326], Stomatobaculum sp. (species) [taxon 1984869], Fusobacterium nucleatum (species) [taxon 851], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Staphylococcus aureus (species) [taxon 1280], Enterobacter cloacae (species) [taxon 550], Spirochaetia (class) [taxon 203692], Bifidobacterium (genus) [taxon 1678], Candida [taxon 1535326], Homo sapiens (human, species) [taxon 9606], Tannerella forsythia (species) [taxon 28112], Streptococcus acidominimus (species) [taxon 1326], Clostridium acetobutylicum (species) [taxon 1488], Campylobacter rectus (species) [taxon 203], Porphyromonas gingivalis (species) [taxon 837], Leptotrichia (genus) [taxon 32067], Klebsiella oxytoca (species) [taxon 571]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12942787/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12942787/full.md

## References

93 references — full list in the complete paper: https://tomesphere.com/paper/PMC12942787/full.md

---
Source: https://tomesphere.com/paper/PMC12942787